Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
---|
05/12/2009 | US7531622 Synthesis and characterization of novel systems for guidance and vectorization of molecules of therapeutic interest towards target cells |
05/12/2009 | US7531516 Antiinflammatory agents; multiple sclerosis; inflamamtory bowel disorders; antitumor agents; sepsis |
05/12/2009 | US7531515 Cancer treatment by administration of a synthetic peptide comprising a sequence of amino acids within the p53 protein and a membrane penetrating leader sequence |
05/12/2009 | US7531514 Orally administered peptides synergize statin activity |
05/12/2009 | US7531512 Method of use of peptide antagonists of zonulin to prevent or delay the onset of diabetes |
05/12/2009 | US7531507 Such as 3-tert-Butyl-D-alanyl-3-(6-trifluoromethylpyridin-3-yl)-L-alanyl-de(1-D-leucyl-2-L-leucyl)-lysobactin bistrifluoroacetate; cell wall biosynthesis inhibitors; treatment and/or prophylaxis of bacterial infectious diseases |
05/12/2009 | US7531506 Process for producing trunkamide a compounds |
05/12/2009 | US7531504 Peptide antagonists of zonulin that bind to the zonula occludens receptor, yet do not physiologically modulate the opening of mammalian tight junctions; tablets, capsules |
05/12/2009 | US7531502 Diagnostic conjugate useful for intracellular imaging and for differentiating between tumor- and non-tumor cells |
05/07/2009 | WO2009059011A2 Hla-dr binding peptides and their uses |
05/07/2009 | WO2009059002A2 Macrocyclization of compounds from solid support using thioesterases |
05/07/2009 | WO2009057982A1 Composition and method for preventing and treating immune-related disorder |
05/07/2009 | WO2009057568A1 Polypeptide compound |
05/07/2009 | WO2009056651A1 Angiotensin-carrier formulation |
05/07/2009 | WO2009056631A2 Molecules and methods for modulating complement component |
05/07/2009 | WO2009056342A1 Binding epitopes for g250 antibody |
05/07/2009 | WO2007129999A3 Antiproliferative peptides and antibodies for their detection |
05/07/2009 | WO2007008684A3 Ligands of melanocortin receptors |
05/07/2009 | US20090119793 Plant Defense Signal Peptides |
05/07/2009 | US20090119019 Small Molecule Mimetics of Erythropoietin |
05/07/2009 | US20090118473 MN Gene and Protein |
05/07/2009 | US20090118198 Novel peptide derivatives useful as antimicrobial agents for treating wounds |
05/07/2009 | US20090118197 Immune-Modulating Peptide |
05/07/2009 | US20090118195 Molecules Which Promote Hematopoiesis |
05/07/2009 | US20090118193 Pegylated mutated clostridium botulinum toxin |
05/07/2009 | US20090118191 Anti-Antiogenic Fragments of Pigment Epithelium-Derived Factor (PEDF) |
05/07/2009 | US20090118174 Novel peptides and methods for the treatment of inflammatory disorders |
05/07/2009 | US20090118171 Use of enzymatic inhibitors of h-prune for the prevention and treatment of the metastases of tumours overexpressing h-prune |
05/07/2009 | US20090118169 Novel compounds and pharmaceutical use thereof |
05/07/2009 | US20090118134 Template Fixed Beta-Hairpin Loop Mimetics and Their Use in Phage Display |
05/07/2009 | US20090117178 with immunogenic or therapeutic properties against ischemic cardiovascular diseases; atherosclerosis |
05/07/2009 | US20090117150 Functional Mutations In Respiratory Syncytial Virus |
05/07/2009 | US20090117140 Human papilloma virus dominant CD4 T cell epitopes and uses thereof |
05/07/2009 | US20090117138 Vaccine for a therapeutic or a prophylactic treatment of myasthenia gravis |
05/07/2009 | US20090117123 Immunopeptides of hpv e6 and e7 proteins |
05/07/2009 | US20090117122 Resistin Antagonists and Their Use |
05/07/2009 | US20090117121 Pseudomonas Aeruginosa Outer Membrane Protein PA0427 |
05/07/2009 | US20090117118 Antibodies specific for sclerostin and methods for increasing bone mineralization |
05/07/2009 | US20090117116 Immunogenic peptides and methods of use for treating and preventing cancer |
05/07/2009 | DE4042752B4 Verfahren zur Herstellung von Mikropartikeln, welche einen Wirkstoff in einem bioabbaubaren polymeren Träger enthalten Process for the preparation of microparticles containing an active agent in a biodegradable polymeric carrier, |
05/07/2009 | CA2704562A1 Polypeptide compound |
05/07/2009 | CA2704397A1 Hla-dr binding peptides and their uses |
05/07/2009 | CA2703911A1 Molecules and methods for modulating complement component |
05/06/2009 | EP2056112A1 Compositions and methods for detection of ehrlichia canis and ehrlichia chaffeensis antibodies |
05/06/2009 | EP2055713A1 Peptide purification by means of metal ion affinity chromatography |
05/06/2009 | EP2055712A1 Peptides and compounds that bind to a thrombopoietin receptor |
05/06/2009 | EP1309336B1 Derivatives of laspartomycin and preparation and use thereof |
05/06/2009 | CN101426809A Rubber composition containing organofunctional silanes |
05/06/2009 | CN101426808A Novel protein transduction domains and uses therefor |
05/06/2009 | CN101426807A Neuroprotective compounds and uses thereof |
05/06/2009 | CN101423546A Radioactive rhenium marked polypeptide containing RGD sequence as well as preparation method and application thereof |
05/06/2009 | CN100484955C Analog of actinomycin D |
05/05/2009 | US7528227 Histone H2A peptide derivatives and uses thereof |
05/05/2009 | US7528223 Polypeptide encoded by an alternative reading frame of an influenza virus |
05/05/2009 | US7528152 synthetic analog of Hemiasterlin; anticarcinogenic agent; restenosis of blood vessels subject to traumas such as angioplasty and stenting; safe and effective, while retaining stability in biological media; exhibit low cytotoxicity to non-dividing normal cells |
05/05/2009 | US7528112 Small survival-promoting/immunomodulatory peptide for treatment of brain damage, neurodegenerative disorders, and inflammatory disorders |
05/05/2009 | US7527794 Nucleotide sequences coding immunoglobulin fusion specific to heparan sulfate proteoglycans for use as diagnostic and therapeutic tool in treatment and prevention of neurodegenerative and cell proliferative disorders |
05/05/2009 | US7527792 Arg-arg-leu-ser-tyr-ser-arg-arg-arg-phe decapeptide bonded to drug such as doxorubicin via maleimide derivative linkage; preventing chemoresistance or drug resistance; gene expression inhibition of multidrug resistance gene |
05/05/2009 | CA2234980C Cyclopeptide derivatives |
04/30/2009 | WO2009055005A2 Competitive inhibitors of invariant chain expression and/or ectopic clip binding |
04/30/2009 | WO2009032978A3 Compositions and methods for diagnosing and treating urinary tract infections |
04/30/2009 | WO2009026155A3 Antimicrobial activity of bovine bactericidal/permeability-increasing protein (bpi) - derived peptides against gram-negative bacterial mastitis isolates |
04/30/2009 | WO2008157483A3 Polypeptides and methods of use |
04/30/2009 | WO2008085794A3 Methods and compositions related to clot binding compounds |
04/30/2009 | WO2007047764A3 Wt1 hla class ii-binding peptides and compositions and methods comprising same |
04/30/2009 | WO2006081301A3 Plant defense signal peptides |
04/30/2009 | WO2004092199A3 Method for identifying modulators of g protein coupled receptor signaling |
04/30/2009 | US20090111756 Monomethylvaline Compounds Having Phenylalanine Carboxy Modifications at the C-Terminus |
04/30/2009 | US20090111755 Methods for the use of inhibitors of antigen presentation by mhc class ii molecules |
04/30/2009 | US20090111753 Nogo-A Polypeptide Fragments, Variant Nogo Receptor-1 Polypeptides, and Uses Thereof |
04/30/2009 | US20090111743 Cysteine-branched heparin-binding growth factor analogs |
04/30/2009 | US20090111738 Fibronectin polypeptides and methods of use |
04/30/2009 | US20090111737 Novel antibacterial agents |
04/30/2009 | US20090111160 fusion protein has trypsin and/or chymotrypsin loop being replaced with a vascular endothelial growth factor binding peptide; a culture product; anticarcinogenic agents, antitumor agents; antiinflammatory agent for treating cartilage and bone disorder; treating dermatitis |
04/30/2009 | US20090111124 Kinase peptides and antibodies |
04/30/2009 | US20090110682 Antibody Having Inhibitory Effect on Amyloid Fibril Formation |
04/30/2009 | US20090110662 Modification of biological targeting groups for the treatment of cancer |
04/30/2009 | DE102008047781A1 Use of an oligopeptide comprising a specific amino acid-sequence for the diagnosis or therapy of a pathological condition in a mammal, preferably human, where the condition is identified by angiogenic processes |
04/30/2009 | CA2703585A1 Competitive inhibitors of invariant chain expression and/or ectopic clip binding |
04/30/2009 | CA2703482A1 Compositions and methods for delivery of glycopeptide antibiotics to medical device surfaces |
04/29/2009 | EP2052253A2 Immunogenic compounds and protein mimics |
04/29/2009 | EP2051992A1 Method for producing condensation products from n-substituted glycine derivatives (peptoids) by sequential ugi-multicomponent reactions |
04/29/2009 | EP1487863B1 Process for purifying glycopeptide phospohonate derivatives |
04/29/2009 | EP1423137B1 Lipopeptide stereoisomers, methods for preparing same, and useful intermediates |
04/29/2009 | EP1343807B1 Diaryl peptides as ns3-serine protease inhibitors of hepatits c virus |
04/29/2009 | EP1115739B1 Auxiliary for amide bond formation |
04/29/2009 | EP0835315B1 Vaccine for porcine reproductive and respiratory syndrome virus |
04/29/2009 | CN101421417A PCR hot start by magnesium sequestration |
04/29/2009 | CN101421299A Peptide vaccine for inducing production of anti-amyloid- -peptide antibody |
04/29/2009 | CN101421291A Process for the manufacture of lysobactin derivatives |
04/29/2009 | CN101418271A Bacillus amyloliquefaciens producing lipopeptide to promote fungi apoptosis and lipopeptide prepared by the same and use |
04/29/2009 | CN101418047A Antigen-antibody compound crystal and preparation method thereof and antigen epitope |
04/29/2009 | CN101418039A Novel antibacterial peptide and preparation method and use thereof |
04/29/2009 | CN101418038A Highland barley peptide and preparation method thereof |
04/29/2009 | CN101418037A Yak bone peptide and preparation method thereof |
04/29/2009 | CN101418036A Rapid purification of gamma trichosanthin and crystallization technology thereof |
04/29/2009 | CN100482683C Active fragment of human glycine-rich protein and use thereof |
04/29/2009 | CN100482682C Novel melanocortin receptor agonists |
04/28/2009 | US7524926 Mucin hypersecretion inhibitors and methods of use |
04/28/2009 | US7524820 Administering one or more enzyme inhibitors, selected from tripeptides, tetrapeptides and pentapeptides, to inhibit neucrosis factor kappa Beta mediated inflammatory cytokine release |